Seeking Alpha
Profile| Send Message|
( followers)  

Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Tuesday July 2.

Food Stocks That Are Acting Like Biotechs: Kellogg (NYSE:K), J.M. Smucker (NYSE:SJM). Other stocks mentioned: Campbell Soup (NYSE:CPB), Tim Hortons (NYSE:THI), Dunkin' Brands (NASDAQ:DNKN), Krispy Kreme (NYSE:KKD), Texas Roadhouse (NASDAQ:TXRH), Bloomin' Brands (NASDAQ:BLMN)

Food stocks, along with other dividend stocks, were sold off when people were afraid Ben Bernanke was going to hold off bond buying. However, technical analyst Tim Collins thinks that this segment could go higher.

Looking at Kellogg's (K) daily chart, Tim Collins sees a bullish crossover of the 13 day and 34 day moving average. He would wait another day to see if this crossover holds. Collins thinks Kellogg could break out over the 66.38 ceiling of resistance and go significantly higher. Kellogg's weekly chart shows the stock trading sideways for 3 months, but the stock is gaining momentum. Collins thinks the stock could go to $77 by the end of the year, an 18% rise above the 17% gain it has already had so far this year. While some might say this is too parabolic a rise, compared to the performance of the S&P 500 for the same period, Kellogg has actually underperformed.

J.M. Smucker's chart shows the same bullish crossover pattern in its daily chart, and the same consolidation and growing momentum in its weekly chart. Collins thinks SJM could break above $105 and could rise as much as to $118.

"These are food stocks, but they are trading like biotechs," said Cramer. While he warned that Collins' view is "controversial," he agrees these stocks are headed higher.

Cramer took some calls:

Campbell Soup Company (CPB) has a good chart, but lacks consistent growth. Cramer would not be a buyer.

Tim Hortons (THI) is participating in the donut bull market. Dunkin' Brands (DNKN) is also good, but Cramer thinks the most resilient of the three has been Krispy Kreme (KKD), which may be headed to $25.

Texas Roadhouse (TXRH) has been putting up good numbers. Cramer also likes Bloomin' Brands (BLMN). "These are two hot stocks."

A New Look At Beaten-Down Stocks: Groupon (NASDAQ:GRPN), Zynga (NASDAQ:ZNGA), Nokia (NYSE:NOK), BlackBerry (NASDAQ:BBRY). Other stocks mentioned: Standard Pacific (NYSE:SPF), Baytex Energy (NYSE:BTE), Pandora (NYSE:P), Siemens (SI), Microsoft (NASDAQ:MSFT)

With the Dow down 43 points because the street has "Cairo on its mind," Cramer took another look at some beaten down stocks that might or might not be worth buying. Cramer has not been a fan of Groupon (GRPN), because he wasn't thrilled with its management. However, when a management shift occurred, Cramer told viewers to stop selling it. His one regret was not having been more aggressive; he thinks he should have told viewers to buy, since it has doubled since then. The stock has more catalysts with its restaurant reservations system and high-end segment.

Zynga (ZNGA) also has new management, and Cramer now gives the company his vote of confidence. While the company has not produced a blockbuster hit game lately, it is showing signs of making deals to acquire new games; "It is not too late to buy Zynga."

Nokia (NOK) has some issues with its deal with Siemens (SI), but it recently bought SI's stake and has an excellent relationship with Microsoft (MSFT). Cramer is no longer a seller of Nokia. Those who want to buy should use call options.

BlackBerry's (BBRY) management doesn't seem to have adequate control over the company's situation, and Cramer would like to see a management change, a break up of the company or to see it taken over. He is not a buyer of BBRY until then.

Cramer took some calls:

Standard Pacific (SPF) will have its buyable moment, but not right now. The problem is that not enough people believe in housing now, but Cramer thinks it is a great company that could be a buy next quarter.

Baytex Energy (BTE): Cramer admits he has not been following BTE because he no longer recommends Canadian Trusts because of the complicated tax and accounting issues. He would stay away.

Pandora (P) is a great growth story that had a great run until it got hit with short sellers. Cramer would wait for a pullback before buying.

CEO Interview: Marty Mucci, Paychex (NASDAQ:PAYX)

Paychex (PAYX) reported an earnings miss with lighter than expected revenues. Cramer doesn't think this is the fault of management, but the lack of growth in small businesses. However, PAYX is a stock that may benefit from higher interest rates, and until then, it pays shareholders a 3.5% yield to wait. CEO Marty Mucci says there is still hiring, but people are worried about regulations and healthcare reform. He thinks that business owners are just holding off rather than scrapping their plans for expansion, and is optimistic about subsequent quarters. With the housing rebound, more jobs may be created, and that may be another catalyst. While he noted that commissions would be coming down, Mucci believes there are significant opportunities to offset it.

::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

Jim Cramer's Action Alerts PLUS: Trade right alongside a Wall Street pro! Start your 14-day FREE trial today.

Get Cramer's Picks by email - it's free and takes only a few seconds to sign up.

Source: Cramer's Mad Money - Food Stocks That Are Acting Like Biotechs (7/2/13)